Google has created website which generates reports on the mobility of a population in a particular area. This tool is designed to assist public health officials to make decisions.
According to the World Health Organization, since 17 February 2020, there have been no new cases of Ebola reported in the ongoing Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo.
This preprint study published information gained on viral shedding of SARS CoV-2 at the University of Nebraska Medical Center. This study observed 13 individuals who were confirmed positive for SARS CoV-2.
An early released paper by the United States Center for Disease Control and Prevention conducted an investigation of all 243 cases of COVID-19 reported in Singapore from January 23–March 16. The investigation identified seven clusters of cases in which presymptomatic transmission is the most likely explanation for the occurrence of secondary cases.
The Lancet published an article on the challenges associated with conducting clinical work on COVID-19 in resource limited settings.
This article documents the findings from a 24-hour point prevalence study conducted at 1150 centers in 88 countries on September 13, 2017. The study found 54% of patients in the ICU had suspected or proven infection; 70% of all patients were receiving at least 1 antibiotic (prophylactic or therapeutic). The hospital mortality was 30% in patients with proven or suspected infection.
As of 29 February 2020 in Wuhan, China, there were 48,557 cases and 2,169 deaths from COVID-19. This study estimated the overall symptomatic case fatality risk.
This article provides the fatality rate and characteristics of COVID-19 patients dying in Italy.
This is a pre-publication version of an article that has undergone peer review and been accepted for publication but is not the final version of record. This study used a retrospective analytical approach, to examine the epidemiological characteristics and transmission patterns of 2143 pediatric patients with COVID-19.
The journal PLoS Medicine released a study indicating Vaxxas (a commercial company) high-density microarray patch (HD-MAP) demonstrated a significantly enhanced immune response to influenza compared to vaccination by syringe.